Orchid Cellmark Extends UK Scrapie Genotyping Contract; Deal Worth More than $7M | GenomeWeb
NEW YORK (GenomeWeb News) - Orchid Cellmark today said it has renewed an ongoing contract with the United Kingdom to continue offering genotyping services to sheep farmers in an effort to combat scrapie.
 
The company reported that the contract, awarded under the National Scrapie Plan for Great Britain, is worth more than $3.5 million per year.
 
The UK government extended the contract through 2007 and 2008, Orchid said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.